IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,574,000 | -28.6% | 144,461 | +4.7% | 0.25% | -34.8% |
| Q4 2020 | $6,402,000 | +23.3% | 137,981 | -12.5% | 0.38% | +9.1% |
| Q3 2020 | $5,193,000 | +40.8% | 157,751 | +17.4% | 0.35% | +31.1% |
| Q2 2020 | $3,689,000 | +4.1% | 134,391 | +13.5% | 0.27% | -7.3% |
| Q1 2020 | $3,545,000 | -7.4% | 118,421 | -14.4% | 0.29% | +8.7% |
| Q4 2019 | $3,829,000 | +39.9% | 138,325 | -8.0% | 0.26% | +32.5% |
| Q3 2019 | $2,737,000 | -23.2% | 150,410 | +3.5% | 0.20% | -20.6% |
| Q2 2019 | $3,565,000 | -3.6% | 145,380 | -62.6% | 0.25% | +9.1% |
| Q1 2019 | $3,699,000 | -27.6% | 388,995 | -14.4% | 0.23% | -29.1% |
| Q3 2018 | $5,111,000 | – | 454,295 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |